University of Pittsburgh
Alzheimer’s Disease Research Center
The University of Pittsburgh Alzheimer’s Disease Research Center (ADRC) is one of the nation’s leading research centers specializing in the diagnosis of Alzheimer’s disease and related disorders.
Memory Evaluation
Donate Now
Upcoming Events
The University of Pittsburgh Alzheimer’s Disease Research Center (ADRC) is one of the nation’s leading research centers specializing in the diagnosis of Alzheimer’s disease and related disorders. Through outpatient evaluations, participants and their families receive state-of-the-art diagnostic assessments and contribute to the scientific study of Alzheimer’s disease.
ADRC Memory Evaluation and Participation in the Research Center
Zinna has been participating since 2014
read more from Zinna and other ADRC volunteers…
Our memory evaluation is an extensive diagnostic evaluation of individuals with suspected Alzheimer’s disease and other types of memory loss and/or cognitive impairment. The professionals at the ADRC understand that this is a stressful process for all and assure that individuals will be treated with sensitivity and respect.
Dementia with Lewy Bodies Consortium
Description: The AHEAD Study is aimed at preventing Alzheimer’s disease (AD) dementia in cognitively normal people who may be at risk with intermediate or elevated levels of amyloid in their brain when measured by a Positron Emission Tomography (PET) scan. Visit AHEADSTUDY.ORG for more information.
Study Length: 4 years
Study Requirements:
- 55 to 80 years of age
- Normal thinking and memory abilities
- Willing to learn your amyloid results (intermediate, elevated, or not elevated) which may relate to your risk of developing AD dementia
- Have a trusted family member or friend (a “study partner”) who can accompany you to a few key study visits and be available by phone to answer questions about your memory and thinking.
- Willing and able to receive regular intravenous (IV) infusions (once or twice a month) of the investigational study drug (BAN2401) or a placebo for up to 4 years
Contact:
Paige Tacey at 412-692-2717 or taceyp@upmc.edu or
Thomas Baumgartner at 412-692-2716 or baumgartnertc@upmc.edu or
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu
Dementia with Lewy Bodies Consortium
Description: The purpose of this study is to collect clinical information, brain imaging scans, and biological samples from people that have dementia with Lewy bodies. This information will help researchers improve the diagnosis, care, and treatment of patients with this disease.
Study Length: 5 years
Study Requirements:
Age 40-90
Diagnosis of Lewy Body Dementia (DLB) or high likelihood
A study partner who will accompany you to all study visits
Contact:
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu
Escitalopram for Agitation in Alzheimer’s Disease (S-CitAD)
Description: The study is designed to examine the efficacy and safety of escitalopram in combination with a psychosocial intervention (PSI) as treatment for agitation in AD patients.
Study Length: 6 months
Study Requirements:
Diagnosis of Alzheimer’s disease with significant agitation/aggression
A study partner who will accompany you to all study visits
Contact:
Patricia Henderson 412-692-2703 or hendersonpl@upmc.edu
FORAging – Facilitating Optimal Routines in Aging
Description: This study is looking at ways to minimize problems with everyday tasks by using a new strategy.
Study Length: 12 months
Study Requirements:
60 years of age AND
Having difficulty managing daily tasks
Contact:
MaryAnn Oakley at 412-692-2721 or oakleym@upmc.edu
PROTECT Depression Research Study
Description: The aim of this study is to understand why some people become depressed and have thoughts of hurting themselves while others do not.
Study Length: 2-3 sessions lasting 2-4 hours each
Study Requirements:
- 50 years old or older
- Recently been feeling depressed
- Never been diagnosed with bipolar depression, a psychotic or neurological disorder
- Never had a stroke
Contact: 412-246-6014 or PROTECT.study@upmc.edu
ADRC Video Spotlight
ADRC participant, Jean, shares her experience at Pitt’s Alzheimer’s Disease Research Center.
Pathways Newsletter
The Spring/Summer 2023 edition of the Pathways Newsletter is now available.